145 related articles for article (PubMed ID: 37591274)
1. Paclitaxel-induced dorsal hand-foot syndrome.
Quan EY; Engel C; Rush PS; Eikenberg JD
Dermatol Online J; 2023 Jun; 29(3):. PubMed ID: 37591274
[TBL] [Abstract][Full Text] [Related]
2. Rare occurrence of hand-foot syndrome due to paclitaxel: A rare case report.
Kataria PS; Kendre PP; Patel AA; Tahiliani N; Bhargav V; Parekh H
Indian J Pharmacol; 2018; 50(5):284-286. PubMed ID: 30636833
[TBL] [Abstract][Full Text] [Related]
3. Management of Paclitaxel-induced hand-foot syndrome.
Assi HA; Ayoub ZA; Jaber SM; Sibai HA; El Saghir NS
Breast Care (Basel); 2013 Jun; 8(3):215-7. PubMed ID: 24415973
[TBL] [Abstract][Full Text] [Related]
4. Liposomal doxorubicin-related palmar-plantar erythrodysesthesia (hand-foot syndrome): a case report.
Ni C; Fang J; Qian H; Xu Q; Shen F
J Int Med Res; 2020 Dec; 48(12):300060520974854. PubMed ID: 33356712
[TBL] [Abstract][Full Text] [Related]
5. Hand-foot syndrome induced by chemotherapy drug: Case series study and literature review.
Zaiem A; Hammamia SB; Aouinti I; Charfi O; Ladhari W; Kastalli S; Aidli SE; Lakhoua G
Indian J Pharmacol; 2022; 54(3):208-215. PubMed ID: 35848692
[TBL] [Abstract][Full Text] [Related]
6. Incidence and implications of chemotherapy related hand-foot syndrome.
Nikolaou V; Syrigos K; Saif MW
Expert Opin Drug Saf; 2016 Dec; 15(12):1625-1633. PubMed ID: 27718746
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel-induced Hand and Foot Syndrome in a Patient with Metastatic Breast Carcinoma.
Gurumurthi R; Nimmagadda RB; Mohan S
Indian J Dermatol; 2013 Sep; 58(5):380-2. PubMed ID: 24082184
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine and Hand-foot Syndrome: A Case Report.
Uppala PK; Varghese AM; Yella SST; Velmurugan H; Thangaraju P; Krishna Sasanka KSBS
Infect Disord Drug Targets; 2023; 23(1):e140622205973. PubMed ID: 35708076
[TBL] [Abstract][Full Text] [Related]
9. Case series of docetaxel-induced dorsal hand-foot syndrome.
Patel J; Ringley JT; Moore DC
Ther Adv Drug Saf; 2018 Aug; 9(8):495-498. PubMed ID: 30364883
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Novel Soaking Solution Used in Patients With Hand-Foot Syndrome as a Result of Capecitabine Treatment: A Randomized and Self-Controlled Trial.
Xie Y; Wang Q; Hu T; Chen R; Wang J; Chang H; Peng X; Cheng J
Clin Breast Cancer; 2022 Jul; 22(5):e685-e690. PubMed ID: 35354530
[TBL] [Abstract][Full Text] [Related]
11. Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report.
Lee SD; Kim HJ; Hwang SJ; Kim YJ; Nam SH; Kim BS
Korean J Intern Med; 2007 Jun; 22(2):109-12. PubMed ID: 17616027
[TBL] [Abstract][Full Text] [Related]
12. Oral hyperpigmentation as an initial clinical aspect of hand foot syndrome.
Santos-Leite ÉGD; Sacramento LV; Santana AM; Dantas JBL; Carrera M; Martins GB
Braz Dent J; 2022; 33(4):97-102. PubMed ID: 36043574
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-induced acral erythema.
Richards KN; Ivan D; Rashid RM; Chon SY
Arch Dermatol; 2012 Nov; 148(11):1333-4. PubMed ID: 23165853
[No Abstract] [Full Text] [Related]
14. Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer.
Eich D; Scharffetter-Kochanek K; Eich HT; Tantcheva-Poor I; Krieg T
Am J Clin Oncol; 2002 Dec; 25(6):599-602. PubMed ID: 12478008
[TBL] [Abstract][Full Text] [Related]
15. Serious hand-and-foot syndrome in black patients treated with capecitabine: report of 3 cases and review of the literature.
Narasimhan P; Narasimhan S; Hitti IF; Rachita M
Cutis; 2004 Feb; 73(2):101-6. PubMed ID: 15027515
[TBL] [Abstract][Full Text] [Related]
16. Topical non-occlusive polymers in hand-foot syndrome.
Fabbrocini G; Cristaudo A; Ionescu MA; Panariello L; Robert G; Pellicano M; Ayala F
G Ital Dermatol Venereol; 2018 Apr; 153(2):165-171. PubMed ID: 29564873
[TBL] [Abstract][Full Text] [Related]
17. Hand-foot syndrome and its impact on daily activities in breast cancer patients receiving docetaxel-based chemotherapy.
Hsu YH; Shen WC; Wang CH; Lin YF; Chen SC
Eur J Oncol Nurs; 2019 Dec; 43():101670. PubMed ID: 31586645
[TBL] [Abstract][Full Text] [Related]
18. Identification of hand-foot syndrome from cancer patients' blog posts: BERT-based deep-learning approach to detect potential adverse drug reaction symptoms.
Nishioka S; Watanabe T; Asano M; Yamamoto T; Kawakami K; Yada S; Aramaki E; Yajima H; Kizaki H; Hori S
PLoS One; 2022; 17(5):e0267901. PubMed ID: 35507636
[TBL] [Abstract][Full Text] [Related]
19. Regorafenib-Induced Hand-Foot Skin Reaction Is More Severe on the Feet Than on the Hands.
Nonomiya Y; Yokokawa T; Kawakami K; Kobayashi K; Aoyama T; Takiguchi T; Sugisaki T; Suzuki K; Suenaga M; Wakatsuki T; Yamaguchi K; Sugimoto Y; Hama T
Oncol Res; 2019 May; 27(5):551-556. PubMed ID: 29914591
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
